Project the fight against cardiovascular diseases
Project the fight against cardiovascular diseases
Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.
УЗНАТЬ ПОДРОБНЕЕ >>>
Of course! Here is a scientific Text on the topic of the project, the fight against cardiovascular diseases is: Project: the fight against cardiovascular diseases — prevention strategies and the improvement of health care Introduction Cardiovascular disease (CVD) is the leading cause of death and are associated with significant socio-economic costs. According to the world health organization (WHO), you are in for nearly 17.9 million deaths annually responsible — that's the equivalent of around 32% of all global deaths. In Germany, HKE are also among the main reasons for premature mortality and long-term disabilities. The aim of this project is to develop an integrated approach to reducing the incidence and prevalence of cardiovascular diseases and to implement. This includes prevention, early diagnosis, as well as improved long-term care of persons Concerned by the focus will be moved. The objectives and priorities of the project The project pursues the following main objectives: Primary prevention: awareness of the population for risk factors such as unhealthy diet, lack of physical activity, Smoking, and excess alcohol consumption. Early detection: introduction of standardized Screening programs for the early identification of hypertension, hyperlipidemia, and Diabetes mellitus. Patient education: development of training programs for individuals with pre-existing cardiovascular risk or disease. Interdisciplinary care: improving coordination between primary care physicians, cardiologists, dieters, and physiotherapists. Data collection and research: the creation of a national registry database for the analysis of the epidemiology, treatment outcomes, and cost structures. Methodology The project will be implemented in three phases: Phase 1 (year 1): analysis of the current supply situation, identification of deficiencies and development of a standardized prevention and treatment Protocol. Phase 2 (years 2-3): piloting the concept in selected regions with different socio-demographic profile. Evaluation of Participation, effectiveness, and cost-Benefit ratio. Phase 3 (year 4-5): scaling a successful approaches at the Federal level, training of the health professional and the implementation of digital support tools (e.g., mobile Apps to control blood pressure). Expected Results It is believed that the implementation of the project shows the following effects: Reduction in the incidence of myocardial infarction and stroke by at least 15% within five years. Increase the early detection rate of high blood pressure from the current 50% to 70%. Improving medication adherence in patients with CVD by 20%. Reduction in admissions to Hospital for congestive heart failure by 10%. Conclusion The proposed project offers a systematic and evidence-based approach to fighting cardiovascular diseases. By linking prevention, early detection and multidisciplinary care can not only increase the quality of life of those Affected, but also the burden on the health care system can be substantially reduced. The results will serve as a basis for future health policy decisions. If you want, I can make certain sections in more detail, or other variants suggest!
People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo. Project the fight against cardiovascular diseases. Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
Cardiovascular disease Code in ICD 10
Acquired diseases of the circulatory System
Scale calculator quickly cardiovascular diseases
In the case of cardiovascular diseases diet appointed
http://gumbaz.ru/posts/817723-npvpn-and-cardiovascular-disease-questions.html
https://holodprof.net/articles/48540-what-are-the-tests-of-cardiovascular-diseases.html
Leaves of the Banaba tree, also known as Crape Myrtle, offer multiple medicinal properties. Scientific studies and research found that it can lower triglyceride levels by 35% and increases good cholesterol level (HDL) by 14%. Not just that, the studies have also shown positive outcomes in cardiovascular diseases, diabetes, and blood pressure. It also has antioxidant properties and helps manage and control weight which ultimately causes the surge in blood flow pressure. Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect.
The scale of the risk of cardiovascular disease: The SCORE approach The assessment of individual risk for cardiovascular events is a Central aspect of the prevention of cardiovascular disease (CVD). To this end, the SCORE developed scale (Systematic COronary Risk Evaluation) — a globally recognized and validated algorithm to estimate the 10‑year risk of a fatal cardiovascular event. Basics and development The SCORE scale is based on data from large-scale epidemiological studies conducted in several European countries. Overall, the cohorts were analyzed, with more than 200 000 participants, the main risk factors for cardiovascular identify diseases and to quantify their collective risk profile. The development of the scale was carried out, taking into account regional differences: There are separate models exist for high-risk and low-risk regions of Europe. Parameters of the SCORE calculation For the risk calculation, the following five independent risk factors be used: Age (Years, 35-70); Gender (male or female); Total cholesterol (mmol/l or mg/dl); ** systolic blood pressure** (mmHg); Smoking (active Smoking Yes/no). Each of these parameters contributes in varying degrees to the overall risk. Thus, an increased systolic blood pressure or elevated cholesterol, for example, the level of a significant increase in Risk. Interpretation of the results The result of the SCORE analysis is specified as a percentage of 10‑year risk: very low risk: <1%; low risk: ≥1%, but <5%; medium risk: ≥5%, but <10%; high risk: ≥10%. A Patient with a SCORE of 5% has heirs, therefore, a 5% probability of death within the next 10 years, the effects of a cardiovascular disease, if no preventive measures are taken. Clinical application and limitations The SCORE scale is primarily used in the primary prevention-that is, the identification of individuals without known cardiovascular disease, however, have an increased risk of h. It helps Physicians to develop individualized prevention strategies — for example, by recommendations for lifestyle change or the initiation of any drug therapy (e.g., lipid-lowering, antihypertensive drugs). Despite its usefulness, the scale also has limitations: They do not take into account all risk factors (e.g., family history of Diabetes mellitus, Obesity). The division into high — and low-risk regions can be styles in times of changing life and risk distributions to be out of date. The scale is for people under the age of 40 and 70 years, only a limited model. Conclusion The SCORE scale is a valuable tool for the objective assessment of the risk of cardiovascular diseases. Their width of validation, simplicity of application and the ability to modify risk factors, make it a cornerstone of cardiovascular prevention in European medicine. A critical Interpretation of the results, taking into account individual characteristics, however, remain necessary.